FGF21 and thyroid cancer: To validate our concept of serum FGF21 level as a predictive biomarker in thyroid cancer, further long-term follow-up studies that measure the serum levels of FGF21 in patients with thyroid cancer at the initial diagnosis, after thyroidectomy, and in those with stable and recurred disease status are necessary.